NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024

A Contract Award Notice
by NHS ENGLAND

Source
Contracts Finder
Type
Framework (Products)
Duration
4 year
Value
£1B
Sector
HEALTH
Published
01 May 2024
Delivery
01 May 2024 to 30 Apr 2028
Deadline
08 Dec 2023 13:00

Concepts

Location

Geochart for 1 buyers and 90 suppliers

1 buyer

90 suppliers

Description

NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024 Offer reference number: CM/PHR/22/5682 CM/PHR/22/5682/01 - NHS Framework Agreement for Branded Medicines - National Tender - Lot 1. Period of framework: 1 May 2024 to 30 April 2028. CM/PHR/22/5682/02 - NHS Framework Agreement for Branded Medicines - National Tender - Lot 2. Period of framework: 1 May 2024 to 30 April 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Award Detail

1 Day Lewis Medical (Croydon)
  • Value: £1,009,500,000
2 Drugsrus (Northwood)
  • Value: £1,009,500,000
3 Neon Healthcare (Hertford)
  • Value: £1,009,500,000
4 Bayer (Reading)
  • Value: £1,009,500,000
5 Ennogen Healthcare (Dartford)
  • Value: £1,009,500,000
6 Fresenius Kabi (Runcorn)
  • Value: £1,009,500,000
7 Aventis Pharma (Reading)
  • Value: £1,009,500,000
8 Selective Supplies (London)
  • Value: £1,009,500,000
9 Rosemont Pharmaceuticals (Leeds)
  • Value: £1,009,500,000
10 Martindale Pharma (Wooburn Green)
  • Value: £1,009,500,000
11 Zentiva Pharma (Guildford)
  • Value: £1,009,500,000
12 Simple Pharma (London)
  • Value: £1,009,500,000
13 Accord (Barnstaple)
  • Value: £1,009,500,000
14 B Braun Medical (Sheffield)
  • Value: £1,009,500,000
15 Janssen Cilag (High Wycombe)
  • Value: £1,009,500,000
16 Glaxosmithkline (Brentford)
  • Value: £1,009,500,000
17 Roche Products (Welwyn Garden City)
  • Value: £1,009,500,000
18 Pfizer (Tadworth)
  • Value: £1,009,500,000
19 Orphalan (London)
  • Value: £1,009,500,000
20 Merck Sharpe & Dohme (London)
  • Value: £1,009,500,000
21 Flexipharm Austrading (Bourne End)
  • Value: £1,009,500,000
22 Flynn Pharma (Stevenage)
  • Value: £1,009,500,000
23 Aguettant (Bristol)
  • Value: £1,009,500,000
24 Mercury Pharmaceuticals (London)
  • Value: £1,009,500,000
25 Abbvie (Maidenhead)
  • Value: £1,009,500,000
26 Clinigen Healthcare (Weybridge)
  • Value: £1,009,500,000
27 Thornton & Ross (Linthwaite)
  • Value: £1,009,500,000
28 Sun Pharma (Uxbridge)
  • Value: £1,009,500,000
29 Valneva (London)
  • Value: £1,009,500,000
30 Venture Healthcare (London)
  • Value: £1,009,500,000
31 Glenmark Pharmaceuticals Europe (Watford)
  • Value: £1,009,500,000
32 Dexcel Pharma (Daventry)
  • Value: £1,009,500,000
33 Alan Pharmaceuticals (London)
  • Value: £1,009,500,000
34 Aop Orphan (Birmingham)
  • Value: £1,009,500,000
35 Brancaster Pharma (Reigate)
  • Value: £1,009,500,000
36 Stirling Anglian Pharmaceuticals (Glasgow)
  • Value: £1,009,500,000
37 Ferndale Pharmaceuticals (Wetherby)
  • Value: £1,009,500,000
38 Aspen Pharmacare (Central London)
  • Value: £1,009,500,000
39 Univar Solutions (Rotterdam)
  • Value: £1,009,500,000
40 Napp Pharmaceuticals (Cambridge)
  • Value: £1,009,500,000
41 Morningside Pharmaeuticals (Loughborough)
  • Value: £1,009,500,000
42 Kyowa Kirin (Galashiels)
  • Value: £1,009,500,000
43 Biovantic Pharma (London)
  • Value: £1,009,500,000
44 Alliance Pharmaceuticals (Chippenham)
  • Value: £1,009,500,000
45 CST Pharma (Walsall)
  • Value: £1,009,500,000
46 Waymade (Basildon)
  • Value: £1,009,500,000
47 Biofrontera Pharma (Leckhampstead)
  • Value: £1,009,500,000
48 Novartis Pharmaceuticals (London)
  • Value: £1,009,500,000
49 Reckitt Benckiser (Slough)
  • Value: £1,009,500,000
50 Teva (Castleford)
  • Value: £1,009,500,000
51 DR Falk Pharma (Bourne End)
  • Value: £1,009,500,000
52 Novo Nordisk (Gatwick)
  • Value: £1,009,500,000
53 Amarox (Harrow)
  • Value: £1,009,500,000
54 Bausch Lomb Pharma (Kingston upon Thames)
  • Value: £1,009,500,000
55 Fontus Health (Walsall)
  • Value: £1,009,500,000
56 A Menarini Farmaceutica Internazionale (Wooburn Green)
  • Value: £1,009,500,000
57 Recordati Rare Diseases (Hemel Hempstead)
  • Value: £1,009,500,000
58 Aspire Pharma (Godalming)
  • Value: £1,009,500,000
59 Ferring Pharmaceuticals (West Drayton)
  • Value: £1,009,500,000
60 Chiesi (Manchester)
  • Value: £1,009,500,000
61 Serb (Weybridge)
  • Value: £1,009,500,000
62 Sandoz (Camberley)
  • Value: £1,009,500,000
63 Amgen (Cambridge)
  • Value: £1,009,500,000
64 Cipla Eu (Addlestone)
  • Value: £1,009,500,000
65 Colonis Pharma (London)
  • Value: £1,009,500,000
66 Cenote Pharma (Newbury)
  • Value: £1,009,500,000
67 Astrazeneca (London)
  • Value: £1,009,500,000
68 Necessity Supplies (Northolt)
  • Value: £1,009,500,000
69 Takeda (London)
  • Value: £1,009,500,000
70 Pari (West Byfleet)
  • Value: £1,009,500,000
71 Tillotts Pharma (Wellingore)
  • Value: £1,009,500,000
72 Lupin Healthcare (Slough)
  • Value: £1,009,500,000
73 Thea Pharmaceuticals (Newcastle)
  • Value: £1,009,500,000
74 Essential Pharma (Egham)
  • Value: £1,009,500,000
75 Wockhardt (Wrexham)
  • Value: £1,009,500,000
76 Merck Serono (Feltham)
  • Value: £1,009,500,000
77 Evolan Pharma (Danderyd)
  • Value: £1,009,500,000
78 Organon Pharmaceuticals (London)
  • Value: £1,009,500,000
79 Tillomed Laboratories (Luton)
  • Value: £1,009,500,000
80 Xiromed (Höllviken)
  • Value: £1,009,500,000
81 Eli Lilly (Basingstoke)
  • Value: £1,009,500,000
82 Pharmacosmos (Reading)
  • Value: £1,009,500,000
83 Luye Pharma (Guildford)
  • Value: £1,009,500,000
84 Uni Health Distribution (Dartford)
  • Value: £1,009,500,000
85 Crescent Pharma (Basingstoke)
  • Value: £1,009,500,000
86 Focus Pharmaceuticals (London)
  • Value: £1,009,500,000
87 Esteve Pharmaceuticals (Maidenhead)
  • Value: £1,009,500,000
88 Typharm (Norwich)
  • Value: £1,009,500,000
89 RPH Pharmaceuticals (Cheadle)
  • Value: £1,009,500,000
90 Tetris Pharma (Marlow)
  • Value: £1,009,500,000

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Contract is suitable for SMEs.

Other Information

Parties Appointed to Framework Agreement - CM_PHR_22_5682 - NHS Branded Medicines National - 1 May 2024 Parties Appointed to Framework Agreement - CM_PHR_22_5682 - NHS Branded Medicines National - 1 May 2024.docx Transparency Award Schedule LOT 02 - NHS Branded Medicines National - 1st May 2024 Transparency Award Schedule LOT 02 - NHS Branded Medicines National - 1st May 2024.pdf Transparency Award Schedule LOT 01 - NHS Branded Medicines National - 1st May 2024 Transparency Award Schedule LOT 01 - NHS Branded Medicines National - 1st May 2024.pdf Framework Agreement and Terms and Conditions CM-PHR-22-5682 - National Branded 1st May 2024 Framework Agreement and Terms and Conditions CM-PHR-22-5682 - National Branded 1st May 2024.pdf

Reference

Domains